ARCHIVES

NTP Committee Accepts Industry Positions On Policy To Separate Figures for Benign, Malignant Lesions

This article is from The Cancer Letter archive.

Vol. 06 No. 44 | November 7, 1980

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

January 31, 2014

Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced

November 18, 1988

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

DCCP To Have Board Of Scientific Counselors

September 1, 1978

Pauling Contends His Applications Included Essentials

April 27, 1979

Boyd’s Rebuttal to DePinho’s Letter to the AAUP

May 30, 2014